MedImaging Integrated Solution Inc.
Medimaging Integrated Solution Inc. engages in the design, manufacture and sale of digital medical imaging diagnostic equipments. It also provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope products, including optical coherence tomography products, control units, scopes… Read more
MedImaging Integrated Solution Inc. (6796) - Net Assets
Latest net assets as of September 2025: NT$698.18 Million TWD
Based on the latest financial reports, MedImaging Integrated Solution Inc. (6796) has net assets worth NT$698.18 Million TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.35 Billion) and total liabilities (NT$650.08 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$698.18 Million |
| % of Total Assets | 51.78% |
| Annual Growth Rate | 17.04% |
| 5-Year Change | 90.23% |
| 10-Year Change | N/A |
| Growth Volatility | 13.37 |
MedImaging Integrated Solution Inc. - Net Assets Trend (2019–2024)
This chart illustrates how MedImaging Integrated Solution Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MedImaging Integrated Solution Inc. (2019–2024)
The table below shows the annual net assets of MedImaging Integrated Solution Inc. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$742.47 Million | -6.31% |
| 2023-12-31 | NT$792.50 Million | +22.27% |
| 2022-12-31 | NT$648.15 Million | +33.33% |
| 2021-12-31 | NT$486.12 Million | +24.55% |
| 2020-12-31 | NT$390.31 Million | +15.47% |
| 2019-12-31 | NT$338.02 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MedImaging Integrated Solution Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 48.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$19.71 Million | 2.66% |
| Common Stock | NT$347.58 Million | 46.81% |
| Other Components | NT$375.17 Million | 50.53% |
| Total Equity | NT$742.47 Million | 100.00% |
MedImaging Integrated Solution Inc. Competitors by Market Cap
The table below lists competitors of MedImaging Integrated Solution Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Amplitech Group Inc
NASDAQ:AMPG
|
$50.17 Million |
|
LG HelloVision Corp
KO:037560
|
$50.23 Million |
|
Peach Property Group AG
SW:PEAN
|
$50.26 Million |
|
Pullup Entertainment Société anonyme
PA:ALPUL
|
$50.27 Million |
|
Mineros SA
TO:MSA
|
$50.15 Million |
|
Alcatel Lucent Teletas Telekomunikasyon AS
IS:ALCTL
|
$50.15 Million |
|
Vietnam National Seed Group JSC
VN:NSC
|
$50.15 Million |
|
CHINA KEPEI ED. DL-00001
F:9CK
|
$50.14 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MedImaging Integrated Solution Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 792,501,000 to 742,467,000, a change of -50,034,000 (-6.3%).
- Net income of 5,610,000 contributed positively to equity growth.
- Dividend payments of 62,250,000 reduced retained earnings.
- New share issuances of 3,480,000 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$5.61 Million | +0.76% |
| Dividends Paid | NT$62.25 Million | -8.38% |
| Share Issuances | NT$3.48 Million | +0.47% |
| Other Changes | NT$3.13 Million | +0.42% |
| Total Change | NT$- | -6.31% |
Book Value vs Market Value Analysis
This analysis compares MedImaging Integrated Solution Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.93x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 7.09x to 3.93x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | NT$10.73 | NT$76.00 | x |
| 2020-12-31 | NT$12.23 | NT$76.00 | x |
| 2021-12-31 | NT$14.91 | NT$76.00 | x |
| 2022-12-31 | NT$18.22 | NT$76.00 | x |
| 2023-12-31 | NT$21.21 | NT$76.00 | x |
| 2024-12-31 | NT$19.36 | NT$76.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MedImaging Integrated Solution Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.76%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.04%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.83x
- Recent ROE (0.76%) is below the historical average (8.31%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 1.41% | 1.52% | 0.63x | 1.49x | NT$-29.02 Million |
| 2020 | 13.87% | 13.45% | 0.65x | 1.58x | NT$15.09 Million |
| 2021 | 13.68% | 13.68% | 0.68x | 1.47x | NT$17.87 Million |
| 2022 | 10.80% | 13.95% | 0.60x | 1.30x | NT$5.20 Million |
| 2023 | 9.34% | 13.79% | 0.40x | 1.69x | NT$-5.20 Million |
| 2024 | 0.76% | 1.04% | 0.40x | 1.83x | NT$-68.64 Million |
Industry Comparison
This section compares MedImaging Integrated Solution Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,274,214,400
- Average return on equity (ROE) among peers: 6.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MedImaging Integrated Solution Inc. (6796) | NT$698.18 Million | 1.41% | 0.93x | $50.16 Million |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.65 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Dynamic Medical Technologies (4138) | $1.76 Billion | 11.67% | 0.71x | $39.41 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |